Rimadyl or Glucosamine
Do You Use Rimadyl or Glucosamine ?J.Arnold: Posted on 11 September 2011
Does your dog have Rimadyl ?Have you ever thought to see if there are natural alternatives which would work equally well in place of the Rimadyl ?The article below, from Chris Adams who is the Staff Reporter of THE WALL STREET JOURNAL, from March 2000, says that 1000 dogs died after taking Rimadyl, and 7000 had bad reactions to it, so even then it was known how potentially harmful Rimadyl is for far too many dogs – and yet now, 11yrs later it is still being used…………Glucosamine,
it is known, rebuilds cartilage and is a safer way of dealing with
arthritis, the main health issue Rimadyl is used for.Vet John Foster MRCVS goes a step further and says that where we see arthritis as a sign of old age, it is more a sign of poor nutrition, and if pets were fed a natural, more appropriate diet, and not commercial petfood, they wouldn’t get it………..worth a think eh ?Article Courtesy of Chris Adams Staff Reporter of THE WALL STREET JOURNAL March 13, 2000
You might call it a made-for-TV drug. Approved for human use in the U.S. but not marketed that way, an arthritis medicine called Rimadyl languished for nearly10 years in developmental limbo, then emerged in a surprising new form: Instead of a human drug, it was now a drug for arthritic dogs. And it became a hit.
With the aid of slick commercials featuring once-lame dogs bounding happily about, Rimadyl changed the way veterinarians treated dogs. “Clients would walk in and say, ‘What about this Rimadyl?’ ” says George Siemering, who practices in Springfield, Va.
Today, those TV spots are gone.
reason has to do with dogs like Montana, a six-year-old Siberian husky
with stiff back legs, Montana hobbled out of a vet’s office in Brooklyn,
N.Y., six months ago accompanied by his human, Angela Giglio, and a
supply of Rimadyl pills. At first, the drug appeared to work. But then
Montana lost his appetite. He went limp, wobbling instead of walking.
Finally he didn’t walk at all. He ate leaves, vomited, had seizures and,
eventually, was put to sleep. An autopsy showed the sort of liver
damage associated with a bad drug reaction. Pet drugs are big business — an estimated $3 billion world-wide — and Rimadyl is one of the bestsellers. It has been given to more than four million dogs in the U.S. and more abroad, brought Pfizer Inc. tens of millions of dollars in sales, and pleased many veterinarians and dog owners. But the drug has also stirred a controversy, with other pet owners complaining that nobody warned them of its risks.
Montana’s owner, Ms. Giglio, is among them. After she informed Pfizer and the
Food and drug administration of her relatively youthful dog’s death,
Pfizer offered her $440 “as a gesture of good will” and to cover part of
the medical costs. Insulted by the offer and a stipulation that she
agree to tell no one about the payment except her tax preparer, she
refused to sign and didn’t take the money. “There’s just no way in my
conscience or heart I can release them from blame,” she says.
reports of bad reactions and deaths started streaming in to the FDA,
the agency suggested that Pfizer mention “death” as a possible side
effect in a warning letter to vets, on labels and in TV ads. Pfizer
eventually did use the word with vets and on labels, but when given an
ultimatum about the commercials — mention “death” in the audio or end
the ads — Pfizer chose to drop them.
director of animal-products technical services, Edward W. Kanara, says
that when reports started coming in, “we acted extremely promptly based
on the information we had.” Pfizer points out that reported adverse
events involve less than 1% of treated dogs.
Rimadyl’s 1997 launch, the FDA has received reports of about 1,000 dogs
that died or were put to sleep and 7,000 more that had bad reactions
after taking the drug, records and official estimates indicate. The FDA
says such events are significantly underreported.
the numbers include cases “possibly” related to Rimadyl, it is hard to
be sure. Many dogs given the arthritis drug are older, and few are
autopsied after they die. Pfizer says it analyzed cases of Rimadyl
treated dogs that died in 1998 and found a link to Rimadyl to be
“likely” in 12%of cases and “not likely” in 22%; it says there was too
little information for a judgment about the others”.